ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0006764 | A genus of the subfamily CALLITRICHINAE occurring in forests of Brazil and Bolivia and containing seventeen species. | Short-Tusked Marmosets|Hapale|marmoset|Callithrix, NOS|Callithrix <subgenus>|Genus Callithrix|Marmoset, Short Tusked|Common Marmoset|Callithrix <genus>|Marmosets|CALLITHRIX JACCHUS|Marmoset, Short-Tusked|Callithrix jacchus jacchus|Callithrix jacchus|callithrix|Genus Callithrix (organism)|Marmoset|Short-Tusked Marmoset|marmosets|Short-tusked marmoset|Callithrix|Marmoset, NOS|MARMOSET|White-Ear-Tufted Marmoset|Cotton-eared Marmoset | Callithrix |
C0018670 | The upper part of the human body, or the front or upper part of the body of an animal, typically separated from the rest of the body by a neck, and containing the brain, mouth, and sense organs. | Head structure (body structure)|Head|Head (volume)|head structure|Head structure|Heads|Head, NOS|HEAD|caput|head|heads|Caput | Head |
C0039729 | Paired bodies containing mostly GRAY MATTER and forming part of the lateral wall of the THIRD VENTRICLE of the brain. | Thalamus, NOS|BRAIN, THALAMUS|Thalamencephalon|Thalamus|Dorsal Thalamus|Thalamencephalons|thalamic|Thalamic|Thalamic structure (body structure)|Thalamic structure|Dorsal thalamus|thalamus|THALAMUS|Dorsal thalamus (Anthoney) | Thalamic structure |
C0036025 | A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as "baker's" or "brewer's" yeast. The dried form is used as a dietary supplement. | S. oviformis|Yeast, Brewers|S. cerevisiae|Yeast, Baker's|SACCHAROMYCES CEREVISIAE|Baker Yeasts|brewer yeast|Saccharomyces cerevisiae (organism)|Saccharomyces oviformis|Saccharomyces cerevisae|Yeast, Brewer's|Saccharomyces cerevisiae|Yeast, Brewer|yeast|brewers' yeast|baker's yeast|Baker's yeast|brewers yeast|Yeast, Bakers|Yeasts, Baker's|S. uvarum var. melibiosus|saccharomyces cerevisiae|Brewer's yeast|Brewers Yeast|Yeast, Baker|Yeasts, Baker|cerevisiae saccharomyces|Brewer's Yeasts|Baker's Yeast|brewer's or baker's yeast|Yeasts, Brewer's|Saccharomyces italicus|Baker Yeast|Saccharomyces Cerevisiae|Saccharomyces uvarum var. melibiosus|Brewer Yeast|Saccharomyces cerevisiae (substance)|Brewers' yeast|S cerevisiae|Bakers Yeast|S. italicus|S. capensis|Brewer's Yeast|brewer's yeast|Baker's Yeasts|Saccharomyces capensis | Saccharomyces cerevisiae |
C0041221 | The agent of South American trypanosomiasis or CHAGAS DISEASE. Its vertebrate hosts are man and various domestic and wild animals. Insects of several species are vectors. | Trypanosoma cruzus|TRYPANOSOMA CRUZI|Trypanosoma triatomae|trypanosoma cruzi|cruzi, Trypanosoma|Trypanosoma cruzi|Trypanosoma escomelis|American trypanosome|Trypanosoma cruzi (organism)|cruzi trypanosoma | Trypanosoma cruzi |
C0008415 | An enzyme that is active in the first step of choline phosphoglyceride (lecithin) biosynthesis by catalyzing the phosphorylation of choline to phosphorylcholine in the presence of ATP. Ethanolamine and its methyl and ethyl derivatives can also act as acceptors. EC 2.7.1.32. | Choline Transphosphatase, ATP|ATP Choline Transphosphatase|Phosphokinase, Choline|Choline kinase (substance)|Choline Phosphokinase|Transphosphatase, ATP Choline|Choline kinase|ATP:choline phosphotransferase|Choline Kinase|Kinase, Choline | Choline Kinase |
C0007227 | Processes and properties of the CARDIOVASCULAR SYSTEM as a whole or of any of its parts. | Cardiovascular Physiological Phenomenas|cardiovascular functioning|Cardiovascular Physiology|Physiology, Cardiovascular|Cardiovascular function|Cardiovascular function (observable entity)|Cardiovascular Physiological Concept|cardiovascular function|Physiological Phenomenon, Cardiovascular|Physiological Concept, Cardiovascular|Phenomena, Cardiovascular Physiological|Physiological Phenomena, Cardiovascular|Phenomenon, Cardiovascular Physiological|cardiovascular physiology|Physiological Concepts, Cardiovascular|Concepts, Cardiovascular Physiological|Cardiovascular function, NOS|Cardiovascular Physiological Phenomenon|Cardiovascular Physiological Concepts|Concept, Cardiovascular Physiological | Cardiovascular Physiological Phenomena |
C0529330 | An angiotensin receptor subtype that is expressed at high levels in a variety of adult tissues including the CARDIOVASCULAR SYSTEM, the KIDNEY, the ENDOCRINE SYSTEM and the NERVOUS SYSTEM. Activation of the type 1 angiotensin receptor causes VASOCONSTRICTION and sodium retention. | Receptor, Angiotensin II Type 1|Angiotensin AT1 Receptor|Angiotensin II Type 1 Receptor|Angiotensin Type 1 Receptor|AT1 Receptor, Angiotensin|Receptor, Angiotensin AT1 | Receptor, Angiotensin, Type 1 |
C0021107 | A surgical procedure that places something in the human body. | Implant procedure, NOS|device placement|implanting|Insertion procedure, NOS|Insertion|implant procedures|Implantation|implant procedure|insertion procedure|Placement|implant|implantation|Implantation procedure (procedure)|Implantation procedure, NOS|IMPLANTATIONS|implantation procedure|Implantation procedure | Implantation procedure |
C0598958 | The physiological processes and techniques used by the body to prevent neuronal injury and degeneration in the central nervous system following acute disorders or as a result of chronic neurodegenerative diseases. | Protection, Neuron|Protection, Neural|Neuronal Protection|Neuroprotection|Protection, Neuronal|Neuron Protection|neuroprotection|Neural Protection | Neuroprotection |
C1284077 | null | Entire hippocampus|Entire hippocampus (body structure) | Entire hippocampus |
C0376466 | A technique in which tissue is rendered resistant to the deleterious effects of prolonged ISCHEMIA and REPERFUSION by prior exposure to brief, repeated periods of vascular occlusion. (Am J Physiol 1995 May;268(5 Pt 2):H2063-7, Abstract) | Preconditioning, Ischemic|Ischaemic preconditioning|Ischemic preconditioning (procedure)|Ischemic Pre-Conditioning|ischemic preconditioning|IPC - ischaemic preconditioning|Ischemic preconditioning|IPC - ischemic preconditioning|Pre-Conditioning, Ischemic|Ischemic Pre Conditioning | Ischemic Preconditioning |
C0003732 | One of the three domains of life (the others being BACTERIA and Eukarya), formerly called Archaebacteria under the taxon Bacteria, but now considered separate and distinct. They are characterized by: (1) the presence of characteristic tRNAs and ribosomal RNAs; (2) the absence of peptidoglycan cell walls; (3) the presence of ether-linked lipids built from branched-chain subunits; and (4) their occurrence in unusual habitats. While archaea resemble bacteria in morphology and genomic organization, they resemble eukarya in their method of genomic replication. The domain contains at least four kingdoms: CRENARCHAEOTA; EURYARCHAEOTA; NANOARCHAEOTA; and KORARCHAEOTA. | Domain Archaea|archaebacteria|Superkingdom Archaea|Archaebacteria|Archaea|Archebacteria|archaeon|Mendosicutes|Metabacteria|Archaeon|archaea archaeon|Archaeobacteria|archaea|Domain Archaea (organism) | Archaea |
C0035500 | A family of phototrophic bacteria, in the order Rhodospirillales, isolated from stagnant water and mud. | Family Rhodospirillaceae|Purple Nonsulfur Bacteria|Bacteria, Purple Nonsulfur|Family Rhodospirillaceae (organism)|Rhodospirillaceae | Rhodospirillaceae |
C0008633 | In a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) | Chromosome|Chromosomes|Chromosome (cell structure)|Chromosomal|Chromosome, NOS|chromosome|chromosomes | Chromosomes |
C0872079 | Temporary, non-covalent binding between protein molecules. Protein-protein interactions occur as a result of intermolecular physical forces and spatial complementation between domains or motifs. This interaction can be either homotypic or heterotypic and effect protein structure, conformation, and function. | interaction protein|protein protein interaction|Protein-protein interactions|interactions protein|protein interaction | Protein-Protein Interaction |
C0001942 | A zinc-containing enzyme which oxidizes primary and secondary alcohols or hemiacetals in the presence of NAD. In alcoholic fermentation, it catalyzes the final step of reducing an aldehyde to an alcohol in the presence of NADH and hydrogen. | ADH|Dehydrogenase, Alcohol|Alcohol dehydrogenase (substance)|Alcohol Dehydrogenase Family|EC 1.1.1.1|alcohol dehydrogenase|ADH - Alcohol dehydrogenase|Alcohol Dehydrogenase (NAD+)|Alcohol:NAD+ oxidoreductase|Alcohol dehydrogenase|alcohol dehydrogenases|Alcohol Dehydrogenase|Alcohol-NAD+ Oxidoreductase|Oxidoreductase, Alcohol-NAD+|alcohol dehydrogenase (ADH)|Alcohol NAD+ Oxidoreductase | Alcohol dehydrogenase |
C0030016 | The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) | Oxidoreductase, NOS|reductase|oxidoreductases|Dehydrogenase|Dehydrogenases|Reductase|OXIDOREDUCTASES|Substance with dehydrogenase mechanism of action|EC 1|dehydrogenase|Reductase (substance)|Reductases|Substance with oxidoreductase mechanism of action (substance)|Substance with dehydrogenase mechanism of action (substance)|Oxidoreductase|oxidoreductase|Oxidoreductases | Oxidoreductase |
C1295748 | null | Arthrobacter sp. | Arthrobacter species |
C0658195 | null | null | sulfide oxidase |
C0007012 | A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. | Carbonic acid gas|carbon dioxides|Carbon dioxide, NOS|Carbonic Anhydride|Carbonic anhydride|Carbon dioxide (substance)|Carbon dioxide gas|CO2 - Carbon dioxide|CO2|Carbon dioxide gas (product)|CARBON DIOXIDE|carbon dioxide|Dioxide, Carbon|Carbon Dioxide|Carbonic Acid Gas|Anhydride, Carbonic|Carbon dioxide|carbon dioxide (CO2) | carbon dioxide |
C0013618 | A chelating agent that sequesters a variety of polyvalent cations such as CALCIUM. It is used in pharmaceutical manufacturing and as a food additive. | Acid, Ethylenedinitrilotetraacetic|Acido edetico|Acide edetique|ethylenediaminetetraacetic acid (EDTA)|edetic acid|{[-(bis-carboxymethyl-amino)-ethyl]-carboxymethyl-amino}-acetic acid|Acid, Ethylenediaminetetraacetic|Edetic Acid|Ethylenediaminetetraacetic Acid|Ethylenediaminetetraacetic acid|Edathamil|N,N'-1,2-Ethanediylbis(N-(carboxymethyl)glycine)|Edetic acid|Glycine, N,N'-1,2-ethanediylbis(N-(carboxymethyl))-|EDTA|edta|Acide ethylenediaminetetracetique|Acidum edeticum|Acid, Edetic|edathamil|N,N'-1,2-Ethane diylbis-(N-(carboxymethyl)glycine)|(ethylenedinitrilo)tetraacetic acid, ion(4-)|ethylenediaminetetraacetic acid|Ethylenedinitrilotetraacetic Acid|EDETIC ACID|EDTA, ion(4-) | edetic acid |
C0062699 | null | 1-(2-hydroxyiminomethylpyridinium)-3-(4-carbamoylpyridinium)-2-oxapropane|HI-6|H16|hi 6|hi-6 nerve gas antidote|1-(((4-(aminocarbonyl)pyridino)methoxy)methyl)-2-((hydroxyimino)methyl)pyridinium dichloride|HI 6|hi-6|((2-hydroxyiminomethylpyridiniummethyl)-(4'- carbamoylpyridiniummethyl))ether dichloride | asoxime chloride |
C0032081 | Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. | extracts plant|plant extracts|Plant extracts|Plant extract product|plant extract|Product containing plant extract|Plant extract (substance)|Product containing plant extract (product)|Extracts, Plant|Plant extract | Plant Extracts |
C0020971 | Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). | immunizations procedure|Immunostimulation|Immunological Stimulations|Stimulation, Immunologic|immunisation|immunoprophylaxis|Stimulation, Immunological|Sensitization, Immunological|immunizations|Immunization|immunization|Stimulations, Immunological|Immunological Sensitizations|Immunisation|Immunization, NOS|Immunoprophylaxis|Immunization procedure|immunostimulation|Administration of substance to produce immunity, either active or passive|Administration of substance to produce immunity, either active or passive (procedure)|immunisations|IMMUNIZATION|Immunizations|Immunological Stimulation|Immunological Sensitization|Immunologic Sensitization|Sensitizations, Immunological|Sensitization, Immunologic|Immunologic Stimulation | Immunization |
C0279025 | Treatment that adds, blocks, or removes hormones. For certain conditions (such as diabetes or menopause), hormones are given to adjust low hormone levels. To slow or stop the growth of certain cancers (such as prostate and breast cancer), synthetic hormones or other drugs may be given to block the body's natural hormones. Sometimes surgery is needed to remove the gland that makes a certain hormone. | Hormone therapy (procedure)|Hormonal therapy|Hormone therapy|Endocrine therapy|HT - Hormone therapy|hormonal therapy|hormones therapy|Hormone Therapy|Hormonal Therapy|therapy hormonal|hormonal therapies|hormone therapies|hormone therapy|therapy, endocrine|Endocrine Therapy|Chemotherapy-Hormones/Steroids|endocrine therapy|hormone treatment | Hormone Therapy |
C0032136 | Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. | Plasmids|pDNA|Plasmid DNA|Plasmid (substance)|plasmids|Plasmid, NOS|plasmid|Plasmid | Plasmids |
C0033362 | A pancreatic polypeptide of about 110 amino acids, depending on the species, that is the precursor of insulin. Proinsulin, produced by the PANCREATIC BETA CELLS, is comprised sequentially of the N-terminal B-chain, the proteolytically removable connecting C-peptide, and the C-terminal A-chain. It also contains three disulfide bonds, two between A-chain and B-chain. After cleavage at two locations, insulin and C-peptide are the secreted products. Intact proinsulin with low bioactivity also is secreted in small amounts. | Proinsulin|proinsulin|Proinsulin (substance) | Proinsulin |
C0005802 | Glucose in blood. | Sugar, Blood|glucose blood|bloods sugar|sugar blood|Blood Glucose|blood sugars|Blood Sugar|blood glucose|blood sugar|Glucose, Blood|Blood sugar|glycemia | Blood Glucose |
C0037993 | An encapsulated lymphatic organ through which venous blood filters. | spleens|Spleen|SPLEEN|Lieno-|Splenic structure|Lien|Spleen, NOS|Spleno-|spleen|Splenic structure (body structure)|Reticuloendothelial System, Spleen|spleno|Splenic|Splen|splenic|Lienal | Spleen |
C0178784 | A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues. An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus. | anatomy organs|Organs (Anatomy)|organ|organs anatomy|Organs|anatomy organ|organs|Organ | Organ |
C0007447 | Positively charged atoms, radicals or groups of atoms which travel to the cathode or negative pole during electrolysis. | cations|Cations|Cation|cation|positively charged particle | Cations |
C0282641 | Genes that are introduced into an organism using GENE TRANSFER TECHNIQUES. | Transgene|transgene|Transgenes | Transgenes |
C0029130 | The 2nd cranial nerve which conveys visual information from the RETINA to the brain. The nerve carries the axons of the RETINAL GANGLION CELLS which sort at the OPTIC CHIASM and continue via the OPTIC TRACTS to the brain. The largest projection is to the lateral geniculate nuclei; other targets include the SUPERIOR COLLICULI and the SUPRACHIASMATIC NUCLEI. Though known as the second cranial nerve, it is considered part of the CENTRAL NERVOUS SYSTEM. | Second Cranial Nerves|cranial nerve II|Nervus Opticus|Optic nerve|Optic nerve structure (body structure)|Nervus opticus [II]|nervus opticus|cranial nerve ii|Cranial Nerves, Second|Nerve, Second Cranial|Cranial Nerve II|NERVE, OPTIC|ON - Optic nerve|Second cranial nerve|Nerves, Second Cranial|Optic Nerves|Optic Nerve|Nerves, Optic|Cranial nerve II|Optic nerve [II]|optic nerves|Cranial Nerve, Second|OPTIC NERVE|Nerve II|optic nerve|Nerve, Optic|Optic nerve structure|Second Cranial Nerve|Nervus opticus|Optic nerve, NOS|Optic nerve (II) | Optic Nerve |
C0011164 | Disturbance of cell integrity and deterioration of normal tissue, cells or organs. | DEGENERATIVE ABNORMALITIES|Degenerative abnormality|degenerates|Tissue Degeneration|degenerations|degenerate|Degeneration|degenerative change|degenerative|Degenerative change|DEGENERATIONS|Degenerated|abnormal degeneration|DEGENERATION|Degenerative abnormality (morphologic abnormality)|Degenerations|degenerating|Degenerative|Degeneration, NOS|Degenerative changes|degeneration|degenerated | Abnormal degeneration |
C0240083 | An abnormal structure or form of the joints, i.e., one or more of the articulations where two bones join. [HPO:probinson] | Anomaly of the joints|abnormalities joint|JOINT ABNORMALITY|Abnormal shape of joints|joint abnormality|Abnormality of the joints | Abnormal joint morphology |
C1267207 | null | Transplanted soft tissues (body structure)|grafts soft tissue|soft tissue graft|Soft tissue graft | Transplanted soft tissues |
C0911014 | A 28-amino acid, acylated, orexigenic peptide that is a ligand for GROWTH HORMONE SECRETAGOGUE RECEPTORS. Ghrelin is widely expressed but primarily in the stomach in the adults. Ghrelin acts centrally to stimulate growth hormone secretion and food intake, and peripherally to regulate energy homeostasis. Its large precursor protein, known as appetite-regulating hormone or motilin-related peptide, contains ghrelin and obestatin. | Ghrelin (substance)|ghrelin|Ghrelin | ghrelin |
C0597357 | A molecule inside or on the surface of a cell that binds to a specific substance and causes a specific physiologic effect in the cell. | protein receptor|receptor protein|Receptor|protein receptors|Receptor (substance)|receptors|Receptors|receptor|proteins receptor|Receptor Protein|receptor proteins | receptor |
C0013470 | The consumption of edible substances. | Eating|Food Intake|food intake|Eat|Food intake (observable entity)|Eating, NOS|eating|Eating (observable entity)|intakes food|Food intake|Intake, Food|food intakes | Eating |
C0041242 | Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. | Trypsin inhibitors|trypsin inhibitors|Inhibitors, Trypsin|Trypsin Inhibitors|Trypsin inhibitor|trypsin inhibitor | Trypsin Inhibitors |
C0597198 | A manner of functioning or operating. | performance|Performance|performances | Performance |
C0028785 | Posterior portion of the CEREBRAL HEMISPHERES responsible for processing visual sensory information. It is located posterior to the parieto-occipital sulcus and extends to the preoccipital notch. | Occipital lobe structure (body structure)|Occipital Lobes|Occipital lobe, NOS|Region, Occipital|Occipital cortex|Lobes, Occipital|lobe occipital|occipital cortex|Lobe, Occipital|occipital lobes|Occipital Lobe|Occipital Region|Regio occipitalis|Occipital Regions|OCCIPITAL LOBES|occipital lobe|Occipital region|Lobus occipitalis|Occipital lobes|Occipital lobe structure|Occipital lobe|Regions, Occipital|OCCIPITAL LOBE|lobus occipitalis|occipital region | Occipital lobe |
C1281018 | null | Entire precuneus|Entire precuneus (body structure) | Entire precuneus |
C1514918 | The operation of accessing information or removing an item from storage. | Retrieval|RETRIEVING | Retrieval - action |
C0567415 | null | Atom|atoms|Atom (substance)|atom|Atoms | Atom (substance) |
C0038351 | An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM. | Gastric|Ventriculus|Gastrointestinal Tract, Stomach|gastric|Stomachs|gaster|stomachs|Stomach, NOS|Gastro-|gastr(o)-|Stomach|STOMACH|gastro|stomach|Gaster | Stomach |
C0024110 | Solitary or multiple collections of PUS within the lung parenchyma as a result of infection by bacteria, protozoa, or other agents. | lung abscess|Pulmonary Abscesses|LUNG, ABSCESS|abscess lungs|Pulmonary abscess|of lung abscess|Pulmonary Abscess|pulmonary abscess|Lung Abscesses|abscesses lung|Lung abscess|Abscess, Lung|Abscesses, Pulmonary|PULMONARY ABSCESS|Abscess of lung (disorder)|Abscess of lung|Abscesses, Lung|Lungs--Abscess|abscess of lung|lung abscesses|Lung Abscess|pulmonary abscesses|LUNG ABSCESS|Abscess, Pulmonary|abscess pulmonary|abscess lung | Lung Abscess |
C0043210 | Human females as cultural, psychological, sociological, political, and economic entities. | female humans|Girl|Human Females|Girls|Woman|women|human female|female|woman|Women|female human|WOMAN|adult female?|Woman (person) | Woman |
C0026782 | Vaccines used to prevent infection by MUMPS VIRUS. Best known is the live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine. | Mumps vaccines|Vaccine, Mumps|Mumps vaccine (substance)|Mumps Vaccine|mumps vaccine|Mumps vaccine|mumps|Mumps live virus vaccine|mumps vaccines|MUMPS VIRUS VACCINE,LIVE|Mumps live virus vaccine (product)|vaccine mumps|mumps virus vaccine | Mumps Vaccine |
C0034496 | Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis. | rabies vaccine, unspecified formulation|Rabies vaccine|rabies vaccine|RABIES VACCINE|rabies, NOS|Vaccine, Rabies|Rabies Vaccines|Vaccines, Rabies|Rabies vaccine (substance)|rabies, unspecified formulation|rabies vaccines|Rabies vaccine (product)|Rabies vaccines|Rabies Vaccine|vaccines rabies | Rabies Vaccines |
C0026780 | An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (From Dorland, 28th ed) | Epidemic Parotitis|Epidemic Parotitides|Mumps|Mumps (disorder)|mumps parotitis|Parotitides, Epidemic|mumps|Parotitis, Epidemic|Infectious parotitis|Mumps parotitis|EPIDEMIC PAROTITIS|epidemic parotitis|epidemic parotiditis|MUMPS|Mumps, NOS|Mumps parotitis (disorder)|Epidemic parotitis | Mumps |
C0025290 | A syndrome characterized by headache, neck stiffness, low grade fever, and CSF lymphocytic pleocytosis in the absence of an acute bacterial pathogen. Viral meningitis is the most frequent cause although MYCOPLASMA INFECTIONS; RICKETTSIA INFECTIONS; diagnostic or therapeutic procedures; NEOPLASTIC PROCESSES; septic perimeningeal foci; and other conditions may result in this syndrome. (From Adams et al., Principles of Neurology, 6th ed, p745) | Aseptic Meningitis|Aseptic meningitis (disorder)|meningitis aseptic|Aseptic meningitis|aseptic meningitis|ASEPTIC MENINGITIS|Meningitis, Aseptic|MENINGITIS, ASEPTIC | Aseptic Meningitis |
C0037803 | Determination of the energy distribution of gamma rays emitted by nuclei. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) | Gamma Spectrometry|Gamma Spectrophotometry|Gamma ray spectrometry|Spectrophotometry, Gamma | Spectrometry, Gamma |
C0025202 | A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) | melanoma malignant|Malignant melanoma, no ICD-O subtype|melanosarcoma|Melanosarcoma|Malignant Melanoma|Melanoma (disorder)|melanoma|MELANOMA MALIGNANT|Malignant melanoma, no International Classification of Diseases for Oncology subtype (morphologic abnormality)|MALIGNANT MELANOMA|Melanoma syndrome|MM - Malignant melanoma|Malignant melanoma, no International Classification of Diseases for Oncology subtype|MELANOMA, MALIGNANT|Melanomas|Malignant melanoma (disorder)|Malignant Melanomas|Melanoma|Malignant melanoma, NOS|Cancer of skin pigment cells|Malignant melanoma|Nevocarcinoma|MELANOMA|melanomas|melanocarcinoma|melanoma syndrome|Melanomas, Malignant|nevocarcinoma|Melanoma, Malignant|cutaneous melanoma|malignant melanoma|Melanocarcinoma|Melanoma, NOS|malignant melanomas | melanoma |
C0020855 | null | IgG1|Immunoglobulin G1|Immunoglobulin IgG1|IgG1 - Immunoglobulin G1|Immunoglobulin IgG1 (substance)|immunoglobulin G1 (IgG1)|Immunoglobulin G subclass 1|igg subclass 1|igg1 | Immunoglobulin IgG1 |
C0020857 | null | IgG2A | IgG2A |
C1516031 | An antitumor response involves destruction of cancer tumor cells primarily by activated T-cells induced to react to antigens recognized as foreign and expressed by the transformed cells. | null | Antitumor Response |
C0042210 | Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases. | Therapeutic vaccine|Vaccine, NOS|Vaccine|Vaccine Therapy|vaccines|Vaccine product (product)|Vaccine product|Vaccine (substance)|Therapeutic vaccine, NOS|VaccineEntityType|vaccine product|therapeutic vaccine|therapeutic vaccines|VACCINES|vaccine|Vaccines | Vaccines |
C0446516 | The superior part of the upper extremity between the SHOULDER and the ELBOW. | Arms|Arms, Upper|Structure of upper extremity between shoulder and elbow|Upper arm structure|Proximal segment of free upper limb|Brachiums|arms|Upper Arms|Regio brachialis|Arm|Structure of upper extremity between shoulder and elbow (body structure)|Brachium|Arm, NOS|Upper Arm|Brachial region|upper arm|Arm, Upper|Upper arm|arm|ARM|Arm between shoulder and elbow | Upper arm |
C0007286 | Entrapment of the MEDIAN NERVE in the carpal tunnel, which is formed by the flexor retinaculum and the CARPAL BONES. This syndrome may be associated with repetitive occupational trauma (CUMULATIVE TRAUMA DISORDERS); wrist injuries; AMYLOID NEUROPATHIES; rheumatoid arthritis (see ARTHRITIS, RHEUMATOID); ACROMEGALY; PREGNANCY; and other conditions. Symptoms include burning pain and paresthesias involving the ventral surface of the hand and fingers which may radiate proximally. Impairment of sensation in the distribution of the median nerve and thenar muscle atrophy may occur. (Joynt, Clinical Neurology, 1995, Ch51, p45) | Carpal canal|CTS1|Entrapment Neuropathy, Carpal Tunnel|CARPEL TUNNEL SYNDROME|Carpal Tunnel Syndrome|MEDIAN NERVE COMPRESSION|carpal tunnel syndrome|Carpal Tunnel Syndromes|Syndromes, Carpal Tunnel|carpal tunnel syndrome (CTS)|Carpal tunnel|MEDIAN NERVE ENTRAPMENT|Distal median nerve compression|CTS|CTS - Carpal tunnel syndrome|carpal tunnel median neuropathy|Distal median nerve entrapment|Median Neuropathy, Carpal Tunnel|Compression Neuropathy, Carpal Tunnel|SYNDROME CARPEL TUNNEL|Median nerve entrapment|Amyotrophy, Thenar, Of Carpal Origin|Carpal tunnel syndrome (disorder)|Syndrome, Carpal Tunnel|Carpal tunnel syndrome|CARPAL TUNNEL SYNDROME|AMYOTROPHY, THENAR, OF CARPAL ORIGIN|median nerve entrapment | Carpal Tunnel Syndrome |
C0458125 | null | endoscopic release carpal tunnel|endoscopic carpal tunnel release|Endoscopic carpal tunnel release (procedure) | Endoscopic carpal tunnel release |
C0334044 | Cells that look abnormal under a microscope but are not cancer. | Dysplasia, NOS|dyscrasia|abnormal cellular structure or growth|dysplastic|DYSPLASIAS|abnormal structure or growth|Dysplasias|Dysplasia|dysplasias|dysplasia|Dysplastic|Dyscrasia|Dysplasia (morphologic abnormality)|dysplasia (abnormal growth) | Dysplasia |
C0018563 | The distal part of the arm beyond the wrist in humans and primates, that includes the palm, fingers, and thumb. | Hand|hand structure|hands|hand|manus|Manus|Hand, NOS|Hands|HAND|Terminal segment of free upper limb | Hand |
C1089415 | null | Pseudokirchneriella subcapitata | Selenastrum capricornutum |
C1550678 | null | Water specimen|water sampling|Water specimen (specimen)|water sample|Water|sample water|Water sample | Water Specimen |
C0043047 | A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) | Water (substance)|Product containing water (medicinal product)|Water-containing product|Hydrogen Oxide|Dihydrogen oxide|Water|WATER|agua|H2O - water|water | water |
C0086930 | null | Risk assessment|risk assessments|risk assessment|Risk assessment (procedure) | Risk Assessment |
C0679154 | null | null | communicativeness |
C0231170 | Any physical or mental impairment that interferes with an individual's ability to perform desired activities. | DISABILITY|Disability (finding)|Disability|disability|Disability, NOS|Disabilities|BODY DISABILITY AND FAILURE STATES|disabilities | Disability |
C0520817 | null | disability physical|disabilities physical|Physical handicap|physical disability|handicaps physical|Physical handicap (finding)|physical handicap | Physical disability |
C0243725 | null | Cycloartenol synthase|2,3-epoxysqualene cycloartenol-cyclase|Cycloartenol synthase (substance)|2,3-Epoxysqualene cycloartenol-cyclase|2,3-epoxysqualene cycloartenol synthase|2,3-oxidosqualene cycloartenol cyclase|2,3-oxidosqualene cycloartenol-cyclase|cycloartenol synthase | Cycloartenol synthase |
C0243725 | null | Cycloartenol synthase|2,3-epoxysqualene cycloartenol-cyclase|Cycloartenol synthase (substance)|2,3-Epoxysqualene cycloartenol-cyclase|2,3-epoxysqualene cycloartenol synthase|2,3-oxidosqualene cycloartenol cyclase|2,3-oxidosqualene cycloartenol-cyclase|cycloartenol synthase | Cycloartenol synthase |
C0950963 | null | null | rubratoxin B |
C0950963 | null | null | rubratoxin B |
C0349382 | null | Green Olive|olives|Olives|GREEN OLIVE|Olive|Olives (substance)|olive | Olives - dietary |
C0071649 | A large class of organic compounds having more than one PHENOL group. | Polyphenol|Polyphenols|Polyphenol (substance)|polyphenols|polyphenol | polyphenols |
C0243264 | A phenolic phytochemical naturally occurring in extra virgin olive oil, with potential antioxidant, anti-inflammatory and cancer preventive activities. Although the mechanisms of action through which hydroxytyrosol exerts its effects have yet to be fully determined, this agent affects the expression of various components of the inflammatory response, possibly through the modulation of the nuclear factor-kappa B (NF-kB) pathway. The effects include the modulation of pro-inflammatory cytokines, such as the inhibition of interleukin-1alpha (IL-1a), IL-1beta, IL-6, IL-12, and tumor necrosis factor-alpha (TNF-a); increased secretion of the anti-inflammatory cytokine IL-10; inhibition of the production of certain chemokines, such as C-X-C motif chemokine ligand 10 (CXCL10/IP-10), C-C motif chemokine ligand 2 (CCL2/MCP-1), and macrophage inflammatory protein-1beta (CCL4/MIP-1b); and inhibition of the expression of the enzymes inducible nitric oxide synthase (iNOS/NOS2) and prostaglandin E2 synthase (PGES), which prevent the production of nitric oxide (NO) and prostaglandin E (PGE2), respectively. In addition, hydroxytyrosol is able to regulate the expression of other genes involved in the regulation of tumor cell proliferation, such as extracellular signal-regulated and cyclin-dependent kinases. Also, hydroxytyrosol scavenges free radicals and prevents oxidative DNA damage. This induces apoptosis and inhibits proliferation in susceptible cancer cells. | 2-(3,4-dihydroxyphenyl)ethanol|hydroxytyrosol|Hydroxytyrosol|HYDROXYTYROSOL|3,4-DHPEA|2-(3,4-Dihydroxyphenyl)ethanol | hydroxytyrosol |
C0221102 | The elimination by an organism of the waste products that arise as a result of metabolic activity. These products include water, carbon dioxide (CO2), and nitrogenous compounds. [ISBN:0192801023] | Excretory function (observable entity)|eliminations|excretion|elimination function of the body|Elimination|excrete|Elimination [PK]|Excretion|excretory function|Excretion, functional|excretory functioning|excretions|Excretory process|Excretory function, NOS|Excretory process (qualifier value)|Excretory function|Excretion, NOS|elimination|excretion process | Excretory function |
C0008838 | An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. | CISPLATIN|cis-platinous diamine dichloride|Peyrone's Salt|Cis-diamminedichloro Platinum (II)|cis-platinum|CACP|CPDD|cis-diamminedichloridoplatinum|platinum diamminodichloride|cis-Platinum II|cis-platinum II|Cis-platinum II|C.I. 77795|Cis-platinum II Diamine Dichloride|cis-DDP|Cisplatin (substance)|cis-Diamminedichloroplatinum|CDDP|(SP-4-2)-diamminedichloroplatinum|cis diamminedichloroplatinum|Diamminodichloride, Platinum|Cismaplat|Cisplatinum|cis Diamminedichloroplatinum|cis-Platinum|cis Platinum|cis-diammine-dichloroplatinum|Platinum, Diaminedichloro-, cis- (8CI)|Peyrone's Chloride|cisplatinum|Platinum, diamminedichloro-, (SP-4-2)-|cis-diamminedichloroplatinum|PDD|Cisplatina|cis-Platinum compound, NOS|DDP|Cis-platinous Diamine Dichloride|platinum, diaminedichloro-, cis- (8CI)|cis platinum compound|Diaminedichloroplatinum|cisplatino|cis-Platinum compound|Cis-dichloroammine Platinum (II)|cis dichlorodiammineplatinum|cis-diamminedichloro platinum (II)|cis-platinum II diamine dichloride|CISplatin|cis platinum|Cisplatin-containing product|Dichlorodiammineplatinum|Cis-platinum|cis-diamminedichloroplatinum(II)|Cysplatyna|Platinoxan|cis-Diamminedichloroplatinum(II)|cis-Diaminedichloroplatinum|Platinum Metallicum|cisplatin|Cis-diamminedichloridoplatinum|(SP-4-2)-Diamminedichloroplatinum|Cis-DDP|Platinum Diamminodichloride|Cisplatin|Cis-diammine-dichloroplatinum|Product containing cisplatin (medicinal product)|cis-Dichlorodiammineplatinum(II)|Cis-diamminedichloroplatinum | cisplatin |
C0206135 | Inorganic compounds which contain platinum as the central atom. | Inorganic Platinum Compounds|Compounds, Plantinum-Containing|Compounds, Inorganic Platinum|Compounds, Platinum|Plantinum-Containing Compounds|Platinum Compounds|Platinum compounds|Plantinum Containing Compounds|Platinum Compounds, Inorganic | Platinum Compounds, Inorganic |
C0006212 | Negative ions or salts derived from bromic acid, HBrO3. | Bromate|bromate | Bromates |
C0010654 | A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. | Cysteine-containing product|L Cysteine|Cysteine (substance)|Cysteine|CYSTEINE|L-Cys|cysteines|L-Cysteine|Product containing cysteine (medicinal product)|(R)-2-Amino-3-sulfanyl-propanoic acid|L-CYSTEINE|Cys|Half Cystine|Free Cysteine|Cisteinum|(2R)-2-amino-3-mercaptopropanoic acid|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteinum|(2R)-2-amino-3-sulfanylpropanoic acid|l cysteine|Cisteina|l-cysteine|cysteine|cysteine l|cys|L-2-Amino-3-mercaptopropionic acid|Half-Cystine|L-cysteine | cysteine |
C0030797 | The space or compartment surrounded by the pelvic girdle (bony pelvis). It is subdivided into the greater pelvis and LESSER PELVIS. The pelvic girdle is formed by the PELVIC BONES and SACRUM. | BODY CAVITY, PELVIC|Structure of pelvis (body structure)|Structure of pelvis|Pelvis, NOS|Pelvic|pelvic|Pelvic region|Region, Pelvic|pelvis|Pelvis|Pelvic Region|Pelvic (qualifier value)|pelvic region|Pelvic Cavity|PELVIS|Pelvic structure | Pelvis |
C0346185 | A malignant germ cell tumor arising from the ovary. Morphologically, it is identical to seminoma and consists of a monotonous population of germ cells with abundant pale cytoplasm and uniform nuclei. The stroma invariably contains chronic inflammatory cells, mostly T-lymphocytes. It responds to chemotherapy or radiotherapy and the prognosis relates to the tumor stage. | dysgerminoma, ovarian|ovarian dysgerminoma|Ovarian Dysgerminoma|Ovarian dysgerminoma|Germ Cell Dysgerminoma of Ovary|Ovarian Germ Cell Dysgerminoma|Dysgerminoma of Ovary|Dysgerminoma of ovary (disorder)|Germ Cell Dysgerminoma of the Ovary|Dysgerminoma of the Ovary | Dysgerminoma of ovary |
C0026809 | Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae. | Mammals, Mice|Genus Mus|Mice|mus|mouse <Mus>|mice|Murine|Mus|Mouse|Genus Mus (organism)|MOUSE|mouse | Mus |
C0007090 | Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. | chemical carcinogen|Carcinogen (substance)|carcinogens chemical|CARCINOGENS|carcinogens|Oncogenic substance, NOS|Carcinogenic chemical, NOS|Carcinogens|carcinogen|Oncogens|carcinogenic chemicals|Chemical Carcinogen|oncogen|Cancer Causing Agents|Carcinogenic chemical compound|Carcinogen, NOS|Carcinogen|oncogens | Carcinogens |
C0033745 | A thin-walled, glandular stomach found in birds. It precedes the gizzard. | Proventriculus (body structure)|Forestomach|PROVENTRICULUS|Proventriculus | Proventriculus |
C0200931 | null | PCR analysis|Polymerase chain reaction analysis (procedure)|Polymerase chain reaction|analysis pcr|Polymerase chain reaction analysis|pcr analysis | Polymerase chain reaction analysis |
C0015111 | A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties. | N-Nitroso-N-Ethylurea|Ethylnitrosourea|Nitrosoethylurea|Urea, N-ethyl-N-nitroso-|1-Ethyl-1-nitrosourea|N-Ethyl-N-nitrosourea|N-ETHYL-N-NITROSOUREA|N Ethyl N nitrosourea|ENU | Ethylnitrosourea |
C0041964 | Antineoplastic agent that is also used as a veterinary anesthetic. It has also been used as an intermediate in organic synthesis. Urethane is suspected to be a carcinogen. | URETHANE|Ethylester kyseliny karbaminove|urethan|Carbamic acid ethyl ester|Uretan etylowy|Aethylurethan|urethane|Urethan (substance)|Urethane|carbamic acid, ethyl ester|Ethyl urethan|Carbamic acid, ethyl ester|Ethyl Carbamate|Carbamidsaeure-aethylester|Carbamate, Ethyl|Urethan|Aethylcarbamat|ethyl carbamate|Uretano|Ethyl carbamate|Urethanum|Ethyl Urethan | urethane |
C0001430 | A benign epithelial tumor with a glandular organization. | ADENOMA, BENIGN|ADENOMA|Benign adenomatous neoplasm (disorder)|tumor of the gland|Adenoma|Adenoma, NOS|Benign adenoma|Adenoma, no subtype (morphologic abnormality)|adenomas|Adenoma, no subtype|Benign adenomatous neoplasm|adenoma|Adenomas|benign adenoma | Adenoma |
C0007137 | A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) | squamous cell carcinomas|Carcinomas, Squamous|Squamous cell epithelioma|Squamous cell carcinoma, no International Classification of Diseases for Oncology subtype (morphologic abnormality)|Carcinoma, Squamous|Squamous cell carcinoma (disorder)|squamous cell carcinoma|Squamous Carcinomas|CARCINOMA EPIDERMOID|Malignant Squamous Cell Tumor|Carcinoma, Epidermoid|Squamous Cell Carcinoma|Carcinoma, Planocellular|Carcinomas, Squamous Cell|Squamous Cell Cancer|Epidermoid Cell Cancer|Planocellular Carcinomas|SCC - Squamous cell carcinoma|Squamous cell carcinoma, no International Classification of Diseases for Oncology subtype|CARCINOMA, SQUAMOUS CELL, MALIGNANT|Epidermoid Carcinomas|Carcinomas, Planocellular|Epidermoid carcinoma|Planocellular Carcinoma|Squamous carcinoma|Malignant Epidermoid Cell Tumor|Malignant Epidermoid Cell Neoplasm|Squamous Cell Carcinoma, NOS|Squamous cell carcinoma|Epidermoid carcinoma, NOS|epidermoid carcinoma|Squamous Cell Epithelioma|squamous carcinomas|Squamous Cell Carcinoma, Not Otherwise Specified|Squamous Carcinoma|Squamous Cell Carcinomas|squamous carcinoma|Carcinoma, Squamous Cell|Malignant Squamous Cell Neoplasm|squamous cell epithelioma|Carcinomas, Epidermoid|Squamous cell carcinoma, no ICD-O subtype|Epidermoid Carcinoma|Squamous cell carcinoma, NOS | Squamous cell carcinoma |
C0000677 | Polycyclic aromatic hydrocarbon found in tobacco smoke that is a potent carcinogen. | 7,12-Dimethylbenz(a)anthracene|dmba|Benz(a)anthracene, 7,12-dimethyl-|DMBA|1,4-Dimethyl-2,3-benzphenanthrene|7,12-dimentylbenzanthracene|Dimethylbenzanthracene|7,12-Dimethylbenzanthracene|dimethylbenzanthracene|9,10-Dimethyl-1,2-Benzanthracene|7,12 Dimethylbenzanthracene|9,10-dimethyl-1,2-benzanthracene (DMBA) | 9,10-Dimethyl-1,2-benzanthracene |
C0596263 | The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years. | carcinogenesis|Carcinogenesis|Carcinogeneses|Oncogenesis|Cancer Induction|Oncogeneses|Tumorigeneses|Tumorigenesis | Carcinogenesis |
C0034677 | Family of retrovirus-associated DNA sequences (ras) originally isolated from Harvey (H-ras, Ha-ras, rasH) and Kirsten (K-ras, Ki-ras, rasK) murine sarcoma viruses. Ras genes are widely conserved among animal species and sequences corresponding to both H-ras and K-ras genes have been detected in human, avian, murine, and non-vertebrate genomes. The closely related N-ras gene has been detected in human neuroblastoma and sarcoma cell lines. All genes of the family have a similar exon-intron structure and each encodes a p21 protein. | Genes, ras|ras gene|ras Gene|ras Genes|RAS gene|gene ras | Genes, ras |
C0001163 | Pathological processes of the VESTIBULOCOCHLEAR NERVE, including the branches of COCHLEAR NERVE and VESTIBULAR NERVE. Common examples are VESTIBULAR NEURITIS, cochlear neuritis, and ACOUSTIC NEUROMA. Clinical signs are varying degree of HEARING LOSS; VERTIGO; and TINNITUS. | Vestibulocochlear Nerve Disorder|Disorder of cranial nerve 8|acoustic nerve disorder|Disorder of eighth cranial nerve|Cranial Nerve VIII Disorders|vestibulocochlear nerve diseases|Eight cranial nerve disorder|Disorder of the vestibulocochlear nerve|Disorder of acoustovestibular nerve|Eighth Cranial Nerve Diseases|Disorder of acoustic nerve, NOS|Acoustic nerve disorder, NOS (see also section X)|Acoustic Nerve Disorder|DISORDERS OF THE ACOUSTIC NERVE|Disorder of eighth nerve|Disorder of vestibulocochlear nerve|Disorders of acoustic nerve|Disorder of the vestibulocochlear nerve, NOS|Vestibulocochlear Nerve Disease|Disorder of eighth nerve, NOS|Disorder of acoustic nerve|Vestibulocochlear Nerve Diseases|Disorder of acoustic nerve (disorder)|Acoustic nerve disorder NOS|Auditory nerve disease or syndrome|Eighth cranial nerve disease or syndrome|Disorder of auditory nerve|Cranial Nerve VIII Diseases|Disorder of acoustic or eighth nerve | Vestibulocochlear Nerve Diseases |
C0007168 | Regulation of the rate of contraction of the heart muscles by an artificial pacemaker. | Artificial Cardiac Pacing|Pacing, Cardiac, Artificial|Pacings, Artificial Cardiac|Artificial Cardiac Pacings|Pacing, Artificial Cardiac|Cardiac Pacings, Artificial | Cardiac Pacing, Artificial |
C0051755 | An autocrine growth factor and mitogen for a broad range of target cells including EPITHELIAL CELLS; FIBROBLASTS and immune cells. It occurs as a membrane-bound protein that can be cleaved to release an active secreted form. | Amphiregulin|amphiregulin|Schwannoma-derived Growth Factor|Schwannoma derived Growth Factor | Amphiregulin |
C0062934 | An enzyme that catalyzes the demethylation of L-homocysteine to L-METHIONINE. | Homocysteine Transmethylase|Transmethylase, Homocysteine|Homocysteine methyltransferase (substance)|Methyltransferase, S-Adenosylmethionine Homocysteine|Homocysteine Methyltransferase, S-Methylmethionine|S-Methylmethionine Homocysteine Methyltransferase|S-Methyltransferase, Homocysteine|Methyltransferase, Homocysteine|S Adenosylmethionine Homocysteine Methyltransferase|S Methylmethionine Homocysteine Methyltransferase|Homocysteine S Methyltransferase|Methyltransferase, S-Methylmethionine Homocysteine|Homocysteine Methyltransferase|Homocysteine methyltransferase|Homocysteine Methyltransferase, S-Adenosylmethionine|S-Adenosylmethionine Homocysteine Methyltransferase | Homocysteine S-Methyltransferase |